Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline

Open Access

Peer-reviewed

Research Article

Hayato Akimoto,

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯
Shinji Oshima,

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯
Akio Negishi,

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯
Kousuke Ohara,

Affiliation Faculty of Pharmaceutical Sciences, Josai International University, Togane, Chiba, Japan
⨯
Shigeru Ohshima,

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯
Naoko Inoue,

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯
Daisuke Kobayashi

* E-mail: dkoba@josai.ac.jp

Affiliation Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan
⨯

Reader Comments (0)

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Suicide
Is the Subject Area "Suicide" applicable to this article?

Thanks for your feedback.
Depression
Is the Subject Area "Depression" applicable to this article?

Thanks for your feedback.
Antidepressants
Is the Subject Area "Antidepressants" applicable to this article?

Thanks for your feedback.
Smoking habits
Is the Subject Area "Smoking habits" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Nicotine replacement therapy
Is the Subject Area "Nicotine replacement therapy" applicable to this article?

Thanks for your feedback.